Position in NEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$514,755
-$422,971 QoQ
Shares Held
69,374
-45.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Schonfeld Strategic Advisors LLC holds $125,736,773 across 21 Diagnostics & Research names. NEO ranks #16 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
178,851 | $22,045,174 | |
| 2 | QGEN |
Qiagen N.V.
|
493,645 | $19,765,545 | |
| 3 | A |
Agilent Technologies, Inc.
|
132,823 | $15,139,165 | |
| 4 | TWST |
Twist Bioscience Corp
|
258,604 | $12,288,862 | |
| 5 | WAT |
Waters Corp /De/
|
32,254 | $9,605,241 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
52,959 | $9,135,427 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
15,003 | $8,430,035 | |
| 8 | DHR |
Danaher Corp /De/
|
40,074 | $7,598,030 |
All Filings in NEO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $514,755 | 69,374 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $937,726 | 128,280 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $268,294 | 16,280 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,041,497 | 70,610 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $796,692 | 57,440 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,309,447 | 80,930 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,087,418 | 88,408 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,198,633 | 136,816 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $577,731 | 67,100 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||